FTCM
BOLD

First Trust Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

First Trust Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-146,692
Closed -$8.78M – 61
2019
Q4 		$8.78M Buy
+146,692
New +$5.51M 2.78% 12

First Trust Capital Management's BOLD Position: Q1 2020 in Review

First Trust Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 146,692 shares — an estimated $8.78M sold.

First Trust Capital Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $8.78M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • First Trust Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • First Trust Capital Management sold 146,692 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $8.78M.
  • First Trust Capital Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • First Trust Capital Management's Audentes Therapeutics, Inc position peaked at $8.78M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on First Trust Capital Management's 13F filing for Q1 2020, filed 15 May 2020.